AGP Executive Report
Last update: 5 hours agoEbola Drug Trial Prep: Mauritius-headquartered Xylomed Pharmaceuticals says it has developed a candidate Ebola treatment and plans a double-blind, randomised Phase 3B clinical trial in DRC, Uganda and South Sudan, aiming to test whether the molecule can stop the virus from replicating. One Health Biodiversity Link: LifeWatch BEeS 2026 opened at Plovdiv Agricultural University, stressing a One Health approach that connects healthy soils, food systems, ecosystems and human health. Public Health & Tech Diplomacy: India and Indonesia announced plans to integrate India’s UPI with Indonesia’s payment system to make cross-border payments and travel easier—leaders also flagged cooperation across health and other sectors. Local Safety Alert: A British tourist is under police investigation in Mauritius after a rental car crash with an electric bicycle left a 15-year-old boy dead; police are working to confirm the exact circumstances. Women’s Health Leadership: A Mauritius-focused commentary highlights women’s underrepresentation in dentistry leadership and specialised roles, while tracing milestones in women’s entry into the profession. Cybersecurity Risk: Reports say Russian hackers accessed UK government and Foreign Office email accounts, with some credentials linked to institutions including the NHS and drug suppliers—raising concerns for critical services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.